Hutch News

Hutch News

Stories tagged 'merkel cell carcinoma'

Galloway receives NCI Outstanding Investigator Award

Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers

Sept. 21, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Denise Galloway of the Fred Hutchinson Cancer Research Center receives a 2017 Outstanding Investigator Award from the National Cancer Institute.

View story >


New integrated research center launches

Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents

Aug. 10, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Denise Galloway heads new collaborative center to research prevention and treatment of infection-related cancers

View story >


Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma

May 31, 2017 | By Rachel Tompa / Fred Hutch News Service

In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.

View story >


With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma

April 3, 2017 | By Susan Keown / Fred Hutch News Service

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 31, 2017

Dr. Philip Greenberg elected to serve on AACR board of directors; five researchers receive awards to explore immunotherapy single-cell RNA sequencing.

View story >


Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer

Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma

March 24, 2017 | by Susan Keown / Fred Hutch News Service

Tom Judd's metastatic Merkel cell carcinoma nearly took his life. But then he enrolled on a trial of an experimental immunotherapy drug.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.